氘可来昔替尼，BMS-986165，德乌拉西丁，氘可来替尼，原料，1609392-27-9主打

中文名称BMS-986165中文同义词化合物BMS-986165;BMS-986165;BMS986165;BMS986165;DEUCRAVACITINIB;氘可来替尼;氘可来昔替尼;德乌拉西丁;6-[(环丙基羰基)氨基]-4-[[2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯基]氨基]-N-(甲基-D3)-3-哒嗪甲酰胺;氘可来替尼(换品名开票)英文名称BMS-986165英文同义词Tyk2-IN-4;TYK2-IN-4;BMS986165;BMS-986165;BMS986165;6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide;Deucravacitinib;Deucravacitinib(BMS986165);Deucravacitinib(TYK2-IN-4;6-cyclopropaneamido-4-{[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino}-N-(2H?)methylpyridazine-3-carboxamide;DeucravacitinibQ:WhatisDeucravacitinibQ:WhatistheCASNumberofDeucravacitinibCAS号1609392-27-9分子式C20H22N8O3

BMS-986165性质储存条件Storeat-20°C溶解度DMF:1mg/ml;DMSO:1mg/Chemicalbookml;DMSO:PBS(pH7.2)(1:2):0.33mg/ml形态Acrystallinesolid

用途BMS-986165是一种新型口服选择性TYK2抑制剂，该药所具有的独特作用机制有望提供一种有前景的口服选择，帮助患者有效控制其银屑病。